Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Voyageur Secures First International Sales Contract worth US$1.9 Million (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Aphria Inc. APHA

Healthcare Drug Manufacturers - Major Cannabis
Aphria, which is headquartered in Ontario, produces and sells medicinal and recreational cannabis. The company operates through retail and wholesale channels in Canada and internationally. Aphria is a main distributor of medical cannabis to Germany and has operations in over 10 countries outside of Canada. However, it does not have exposure to the U.S. CBD or THC markets due to the constraints of federal prohibition. It has some U.S. exposure through the acquisition of SweetWater, a craft brewer


NDAQ:APHA - Post by User

Aphria Inc. > Read this folks. Canopy trying to catch up to us
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(17)
•••
Post by OhYaBabyon Apr 11, 2021 10:20am
353 Views
Post# 32974056

Read this folks. Canopy trying to catch up to us

Read this folks. Canopy trying to catch up to us

Aphria Tilray dominate the world in cannabis. You think I make these things up. Read the link. You think canopy should have a higher evaluation then us?  No company should in the cannabis game. ORganigram had a modest investment from British American tobacco but just imagine what investment Aphria and tilray will receive. Major companies are looking to get in now just as British American tobacco just did. Constellation and Altria pulled the trigger a little to early but the time to get in is definitely now. I expect a partnership very shortly after the merger. Owning shares in Aphria Tilray can never be a bad thing at this point.  Read and open your eyes. WORLDWIDE

https://technical420.com/cannabis-article/aphria-and-tilray-sparked-an-ma-super-cycle-and-this-is-what-comes-next/

<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities